News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Jemma Arakelyan: Ready to learn, share, and connect at ASCO 2025
Jemma Arakelyan/LinkedIn
May 31, 2025, 09:36

Jemma Arakelyan: Ready to learn, share, and connect at ASCO 2025

Jemma Arakelyan, Medical Oncologist and CEO of Institute of Cancer and Crisis, shared on LinkedIn:

“A milestone moment: collected my inaugural ASCO badge in my capacity as faculty. Honored to stand with the leaders driving oncology forward. The energy here is unmatched. Ready to learn, share, and connect!”

Jemma Arakelyan: Ready to learn, share, and connect at ASCO 2025

More posts featuring Jemma Arakelyan on OncoDaily.

ASCO 2025 cancer Institute of Cancer and Crisis Jemma Arakelyan OncoDaily Oncology
Special Coverage
Drugs
Jul 13, 2025, 03:48
Zynyz (Retifanlimab-dlwr): What Patients Should Know in 2025?
Blog
Jul 13, 2025, 00:47
Luciano J Costa: Most Innovation in Multiple Myeloma is from China
Blog
Jul 12, 2025, 23:29
Paolo Tarantino: CDK4/6 inhibitor rechallenge/switch - should we?
Blog
Jul 12, 2025, 23:19
Surbhi Sidana: A privilege to lead this committee of amazing hematologists
Blog
Jul 12, 2025, 22:47
Amir Safavi: Thank you Nancy Lee for the productive year of Olympian training at MSKCC
Blog
Jul 12, 2025, 21:16
Ishwaria Subbiah: Teaching Cancer Pain Management to Over 100 East Asian Oncology and Palliative Care Professionals
Blog
Jul 12, 2025, 20:41
Nina Niu Sanford: An Overview of Rectal Cancer Management in 2025 - Slides for the Teaching Videos are Available
Insight
Jul 12, 2025, 20:03
Mario Balsa: When it comes to 5-FU, less might just be more for the marrow
Insight
Jul 12, 2025, 19:37
Stephen V Liu: Stereotactic radiation for treatment of brain metastases in SCLC
Blog
Jul 12, 2025, 19:23
Bishal Gyawali: Does practicing board exam questions make you a better oncologist
Blog
Jul 12, 2025, 19:10
Herbert Loong: Our PhD Candidate on His Ongoing Project on Immunotherapy Sensitivity in Leiomyosarcomas
Blog
Jul 12, 2025, 18:58
Nicholas Vitanza: I Never Expected to Be an R37 MERIT Award...